Novavax Reports reports full year and fourth quarter 2016 results
Novavax reported the net loss was $280.0 million, or $1.03 per share, in the 2016 year end versus a net loss of $156.9 million, or $0.60 per share, for the same 2015 period. Revenue for the full year 2016 decreased 58% to $15.4 million, compared to $36.3 million in 2015. February 27, 2017